| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Former Director | EVP, R&D &Chief Scientific Of +1 more
3 companies
Haqq Christopher serves as an EVP, R&D &Chief Scientific Of at ATRA and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 50 sells. Those positions are worth an estimated $10.8M at current prices.
The biggest single holding is ATRA (~$10.8M) as EVP, R&D &Chief Scientific Of. The recent filings there lean toward selling, a net 243,103 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2019 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 775 | $39.59 | $30,682.25 | -0.3% | |
| Feb 11, 2019 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 13,975 | $38.55 | $538,736.25 | -4.9% | |
| Feb 6, 2019 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 12,375 | $38.62 | $477,921.52 | -4.3% | |
| Nov 15, 2018 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 775 | $33.81 | $26,202.75 | -0.3% | |
| Sep 26, 2018 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 13,500 | $43.08 | $581,580.00 | -4.5% | |
| Sep 25, 2018 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 31,500 | $40.17 | $1,265,330.49 | -9.5% | |
| Aug 15, 2018 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 775 | $37.54 | $29,093.50 | -0.2% | |
| May 15, 2018 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sale+OE | 25,775 | $45.30 | $1,167,480.42 | -7.2% | |
| Mar 26, 2018 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sell | 18,327 | $39.79 | $729,264.52 | -5.2% | |
| Nov 15, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP, R&D &Chief Scientific Of | Sale+OE | 1,604 | $13.36 | $21,429.44 | -0.5% |